Exhibit 107
Calculation of Registration Fee
| Title of securities to be registered | Amount to be registered(1) | Proposed maximum offering price per share(3) | Proposed maximum aggregate offering price(3) | Amount of registration fee | ||||||||||||
| Common stock, $0.0001 par value, to be issued pursuant to the Second Amended and Restated 2019 Stock Incentive Plan of INVO Bioscience, Inc. | 1,142,759 Shares (2) | $ | 0.529 | $ | 604,519.51 | $ | 66.62 | |||||||||
| (1) | This Registration Statement shall also cover any additional shares of common stock which become issuable under the Plan being registered pursuant to this Registration Statement by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of our outstanding shares of common stock. |
| (2) | Reflects (1) 412,802 additional shares approved at the Registrant’s annual meeting of stockholders on October 12, 2022 and (ii) an automatic increase to the number of shares of the Registrant’s common stock reserved for issuance pursuant to future awards under the Second Amended and Restated 2019 Stock Incentive Plan (the “Plan”), which annual increases are provided for in the Plan |
| (3) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based upon the average of the high and low sale price of the Registrant’s common stock on January 13, 2023 as reported in the Nasdaq Stock Market. |
